{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Beal MA"],"funding":["Intramural EPA"],"pagination":["123-139"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8973434"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["39(1)"],"pubmed_abstract":["Internationally, there are thousands of existing and newly introduced chemicals in commerce, highlighting the ongoing importance of innovative approaches to identify emerging chemicals of concern. For many chemicals, there is a paucity of hazard and exposure data. Thus, there is a crucial need for efficient and robust approaches to address data gaps and support risk-based prioritization. Several studies have demonstrated the utility of in vitro bioactivity data from the ToxCast program in deriving points of departure (PODs). ToxCast contains data for nearly 1,400 endpoints per chemical, and the bioactivity concentrations, indicative of potential adverse outcomes, can be converted to human-equivalent PODs using high-throughput toxicokinetics (HTTK) modeling. However, data gaps need to be ad"],"journal":["ALTEX"],"pubmed_title":["Implementing in vitro bioactivity data to modernize priority setting of chemical inventories."],"pmcid":["PMC8973434"],"funding_grant_id":["EPA999999"],"pubmed_authors":["Thomas RS","Patlewicz G","Kulkarni SA","Beal MA","Gagne M","Barton-Maclaren TS"],"additional_accession":[]},"is_claimable":false,"name":"Implementing in vitro bioactivity data to modernize priority setting of chemical inventories.","description":"Internationally, there are thousands of existing and newly introduced chemicals in commerce, highlighting the ongoing importance of innovative approaches to identify emerging chemicals of concern. For many chemicals, there is a paucity of hazard and exposure data. Thus, there is a crucial need for efficient and robust approaches to address data gaps and support risk-based prioritization. Several studies have demonstrated the utility of in vitro bioactivity data from the ToxCast program in deriving points of departure (PODs). ToxCast contains data for nearly 1,400 endpoints per chemical, and the bioactivity concentrations, indicative of potential adverse outcomes, can be converted to human-equivalent PODs using high-throughput toxicokinetics (HTTK) modeling. However, data gaps need to be ad","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-21T15:18:13.52Z","creation":"2025-04-21T15:18:13.52Z"},"accession":"S-EPMC8973434","cross_references":{"pubmed":["34818430"],"doi":["10.14573/altex.2106171"]}}